A retrospective, multicenter cohort study assessing effectiveness and renal safety of switching from entecavir or nucleostide analogue combination therapy to Tenofovir alafenamide (TAF)
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2021 New trial record